Correction: Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational Study at 25 Months.
Saved in:
| Title: | Correction: Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational Study at 25 Months. |
|---|---|
| Authors: | Thaçi, Diamant1 (AUTHOR) Diamant.Thaci@uksh.de, Ohtsuki, Mamitaro2 (AUTHOR), Maul, Julia-Tatjana3,4 (AUTHOR), Szegedi, Andrea5 (AUTHOR), Luna, Paula C.6 (AUTHOR), Lynde, Charles W.7 (AUTHOR), Soliman, Ahmed M.8 (AUTHOR), Wang, Hongwei8 (AUTHOR), Kaufmann, Christian8 (AUTHOR), Ashley, Doug G.8 (AUTHOR), Madihlaba, Tshepiso8 (AUTHOR), Rubant, Simone8 (AUTHOR), Papp, Kim A.9,10 (AUTHOR) |
| Source: | Dermatology & Therapy. Jun2025, Vol. 15 Issue 6, p1595-1597. 3p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 21938210 |
|---|---|
| DOI: | 10.1007/s13555-025-01420-3 |
